Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies

Updates from the PROpel and MAGNITUDE studies

Update on the latest in PARP inhibitors for prostate cancer

ASCO Direct Highlights 2022: prostate cancer highlights

Updates in bladder, kidney and testes cancer from ASCO 2022

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

War in Ukraine: Global cancer aid to support refugees

ASCO and WHO to collaborate on quality indicators for cancer facilities

Spotlight on global cancer control at ASCO 2022

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

ASCO 2022: Highlights and analysis

ASCO 2022: Latest in prostate cancer, including PARP inhibitors